OTA Financial Group’s Viking Therapeutics, Inc. VKTXW Stock Holding History

OTA Financial Group’s Portfolio VKTXW Stock Details VKTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,883	Closed	-$214K	–	61
2019 Q1	$214K	Buy	+23,883	New	+$163K	0.18%	35

Other funds holding VKTXW

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OTA Financial Group's VKTXW Position: Q2 2019 in Review

OTA Financial Group sold out of Viking Therapeutics, Inc. (VKTXW) in Q2 2019, closing a stake of 23,883 shares — an estimated $214K sold.

OTA Financial Group first reported a position in VKTXW in Q1 2019 and held it in 1 quarter. The position peaked at $214K in Q1 2019. 4 funds tracked by Wall St. Rank hold VKTXW as of Q2 2019.

OTA Financial Group reported no remaining Viking Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
OTA Financial Group sold 23,883 Viking Therapeutics, Inc. shares in Q2 2019, an estimated $214K.
OTA Financial Group first reported a position in Viking Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
OTA Financial Group's Viking Therapeutics, Inc. position peaked at $214K in Q1 2019.
4 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q2 2019.

Based on OTA Financial Group's 13F filing for Q2 2019, filed 22 Jul 2019.